Laboratory identification of hereditary risk of breast and ovarian cancer

被引：2
|
作者：
Frank, TS [1 ]
机构：
[1] Myriad Genet Labs, Salt Lake City, UT 84108 USA
来源：
CURRENT OPINION IN BIOTECHNOLOGY | 1999年 / 10卷 / 03期
关键词：
D O I：
10.1016/S0958-1669(99)80051-2
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：289 / 294
页数：6
相关论文
共 50 条
  • [41] Hereditary Breast and Ovarian Cancer Syndrome
    Modesitt, Susan C.
    Lu, Karen
    Chen, Lee-May
    Powell, C. Bethan
    OBSTETRICS AND GYNECOLOGY, 2017, 130 (03): : E110 - E126
  • [42] Hereditary breast and ovarian cancer syndrome
    Tamaki, Yasuhiro
    CANCER SCIENCE, 2018, 109 : 778 - 778
  • [43] Pharmacoprevention for hereditary breast and ovarian cancer
    Cazzaniga, Massimiliano
    Bonanni, Bernardo
    MINERVA GINECOLOGICA, 2016, 68 (05): : 517 - 535
  • [44] The prevalence of ovarian cancer in Korean women at high risk of hereditary breast-ovarian cancer syndrome
    Lee, J.
    Han, S.
    Lim, C.
    Kang, E.
    Kim, S. -W.
    Park, S. K.
    Ahn, S.
    Lee, H. -D.
    Jeong, J.
    Lee, M. H.
    BREAST, 2011, 20 : S29 - S29
  • [45] The Prevalence of Ovarian Cancer in Korean Women at High-Risk for Hereditary Breast-Ovarian Cancer
    Lee, Jihyoun
    Kang, Eunyoung
    Kim, Sung-Won
    Park, Boyoung
    Park, Sue K.
    Ahn, Sei-Hyun
    Lee, Hy-De
    Jeong, Joon
    Jung, Sung Hoo
    Lee, Byoung Kil
    Chang, Myung Chul
    Bae, Young Tae
    Cho, Young Up
    Hwang, Ki-Tae
    Kim, Hyun-Ah
    Kim, Eun-Kyu
    Paik, Nam Sun
    Han, Sehwan
    Yoon, Chan Seok
    Lee, Min Hyuk
    JOURNAL OF BREAST CANCER, 2011, 14 : S24 - S30
  • [46] Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer
    Pruthi, Sandhya
    Gostout, Bobbie S.
    Lindor, Noralane M.
    MAYO CLINIC PROCEEDINGS, 2010, 85 (12) : 1111 - 1120
  • [47] There is no place for ovarian cancer screening in hereditary breast-ovarian cancer syndromes (in regard to "ESMO Clinical Practice Guideline on risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes")
    Sessa, C.
    Paluch-Shimon, S.
    ANNALS OF ONCOLOGY, 2024, 35 (01) : 139 - 140
  • [48] Women with increased risk for hereditary breast and/or ovarian cancer do not have diminished ovarian reserve
    Sighinolfi, G.
    Imbrogno, M. G.
    Grandi, G.
    Toss, A.
    Barbieri, E.
    Razzaboni, E.
    La Marca, A.
    HUMAN REPRODUCTION, 2022, 37 : I518 - I519
  • [49] A case of simultaneous breast cancer and ovarian cancer based on a hereditary breast and ovarian cancer syndrome
    Kotaka, Saki
    Yasui, Hiroaki
    Tsubouchi, Hirofumi
    Mori, Masahiko
    Kotani, Haruru
    Yoshimura, Akiyo
    Ouchi, Akira
    Okuno, Masataka
    Komori, Koji
    Shimizu, Yasuhiro
    Suzuki, Shiro
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2023, 85 (04): : 814 - 821
  • [50] Managing hereditary ovarian cancer risk
    Berchuck, A
    Schildkraut, JM
    Marks, JR
    Futreal, PA
    CANCER, 1999, 86 (08) : 1697 - 1704
12345